1. Home
  2. GENK vs RGNT Comparison

GENK vs RGNT Comparison

Compare GENK & RGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GEN Restaurant Group Inc.

GENK

GEN Restaurant Group Inc.

HOLD

Current Price

$1.67

Market Cap

12.8M

ML Signal

HOLD

Logo Regentis Biomaterials Ltd. Ordinary Shares

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

HOLD

Current Price

$1.77

Market Cap

13.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GENK
RGNT
Founded
2011
2004
Country
United States
Israel
Employees
2700
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.8M
13.3M
IPO Year
2023
2022

Fundamental Metrics

Financial Performance
Metric
GENK
RGNT
Price
$1.67
$1.77
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$4.50
N/A
AVG Volume (30 Days)
63.6K
22.5K
Earning Date
05-13-2026
05-05-2026
Dividend Yield
1.88%
N/A
EPS Growth
62.50
N/A
EPS
N/A
N/A
Revenue
$208,380,000.00
N/A
Revenue This Year
$4.79
N/A
Revenue Next Year
$7.48
N/A
P/E Ratio
N/A
N/A
Revenue Growth
15.12
N/A
52 Week Low
$1.43
$1.23
52 Week High
$3.21
$15.50

Technical Indicators

Market Signals
Indicator
GENK
RGNT
Relative Strength Index (RSI) 36.23 43.76
Support Level $1.49 $1.82
Resistance Level $1.73 $2.27
Average True Range (ATR) 0.11 0.11
MACD -0.03 -0.01
Stochastic Oscillator 31.91 36.59

Price Performance

Historical Comparison
GENK
RGNT

About GENK GEN Restaurant Group Inc.

GEN Restaurant Group Inc operates an Asian casual dining restaurant chain, offering an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables. The group operates its restaurants in California, Arizona, Hawaii, Nevada, Texas, New York, Oregon, North Carolina, Washington, New Jersey, Florida and South Korea.

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

Share on Social Networks: